Merck, the Fda and the Vioxx Recall Essay

Central Problem In the Merck, the FDA, and the Vioxx Recall case study, the question as to whether or not Merck conducted itself in a socially responsible and ethical manner with regard to Vioxx is the central problem we will examine in this case. Many argue that the sole problem lies within the pharmaceutical company Merck and Co., Inc., and while that may in fact be the case, other parties such as the Food and Drug Administration (FDA) can be held responsible as well. Merck a “research driven” pharmaceutical

Vioxx Recall Keri Sexton Stevens-Henager College Author Note Keri Sexton, Department of Medical Specialties, Stevens-Henager College. Correspondence concerning this article should be addressed to Keri Sexton, Department of Medical Specialties, Stevens-Henager College, 1444 South Entertainment Avenue, Boise, Idaho, 83709. Contact: keri.sexton208@gmail.com   Vioxx Recall There has been a great deal of controversy surrounding the voluntarily recall of Vioxx by Merck. They initially went on record

Background on the Case Study For years, Merck had been a successful and reputable pharmaceutical company that was known for its high-quality products and world-class research centres, and was often regarded in a good light compared to its less favourable competitors. However, all this fell apart in the early 2000s with the recall of the company’s “blockbuster” drug “Viroxx.” It was meant to act similar to ibuprofen in ways that it cured osteoarthritis and acute pain, but was withdrawn in 2004 after

Question 1 Merck was known as an ethical and socially responsible drug manufacturer. Back in 1950, George W. Merck, CEO, said, “We try never to forget that medicine is for the people. It is not for the profits” (Lawrence & Weber, 2014). Merck was also known for research and innovation in developing new drugs as well as their philanthropic efforts. This was a company that had built its success on a solid reputation of being an ethical and socially responsible organization. The Vioxx case is evidence

the Product recall involving the Drug Company known as Merck, who produced the drug Vioxx use to treat osteoarthritis, and acute pain in adults. Looking at the relationships Merck had with government and lobbyist one can see what actions the drug company may have taken to lead them to this recall. In Addition, This paper will look at the actions Merck took in the approval process and recall of their drug. Using all information provided on this case this paper will decide whether Merck was ethically

Merck and the Recall of Vioxx Florence N. Wandera MGT 600 – Corporate Responsibility & Bus Law Merck and the Recall of Vioxx Case Summary Merck & Co. Inc. is a global research-driven pharmaceutical company that develops, manufactures and markets a broad range of human health products. One such product is Vioxx, developed in 1994 and approved on May 21, 1999 by the United States Food and Drug Administration (FDA) for the treatment of pain, inflammation, and stiffness caused by arthritis

Merck, the FDA, and the VIOXX Recall MBA 520-D4C2 Ethics & Leadership in a Global Environment April 22, 2012 Merck and Vioxx Recall Did Merck act in social and ethical manner? In 2005, Merck was ranked fourth in sales among pharmaceutical companies. Merck had released the drug Vioxx, for treating Osteoarthritis in late 1990. Merck as a company has a reputation of being one of the most ethical and

balance, do you think Merck is an ethical and socially responsible company? Why or why not? How about Pfizer? In my opinion, Merck is not an ethical and socially responsible company with introducing Vioxx into pharmaceutical market. Before the Vioxx approval by FDA, scientists from University of Pennsylvania found that the drug could bring some serious results such as cardiovascular, and there were many serious cardiovascular problems during testing on patients. However, Merck ignored these negative

profitability and maximizing shareholder wealth. In this case, Merck had to decide between profits at the center of the company’s shareholders wealth, the company’s image from a corporate social responsibility perspective, and the welfare of the community. The company had a responsibility to safely serve the public and meet the interest of all parties involved without compromising the interests of key stakeholders. Merck's practices regarding the Vioxx debacle were clearly designed towards generating profits

promising for many years until it was pulled off from the market in 2001 due to the thirty deaths that were linked with the drug. Bayers has been dealing with the aftermath ever since. The drug was pulled from the market due to it’s reports to the FDA of development of rhabdomyolysis—a rare disorder in which muscles tissue is broken down and can lead to organ failure and death—in patients who took the drug! There have been accusations during Bayer’s lawsuit from the many families of those who died